hapabapa Investment Thesis Affirm (NASDAQ:AFRM) delivered impressive fiscal Q4 2024 results and fiscal 2025 guidance. More specifically, it appears that Affirm is demonstrably a growth company. And while it continues to grow its top line, it's also carving out a path towards clean GAAP profitability. In sum, I make the case that AFRM is attractively priced at 17x forward non-GAAP operating profits. As such, I rate this stock a buy. Rapid Recap On 23 May, I said in a neutral AFRM article,    [...] You ma ...